• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

139
17
13
11
11

COUNTRY

4
3
3
3
3

PRICE

85
116
314
449

PUBLISHED

1
10
88
449

PRODUCT TYPE

440
7
1
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE
Disease & Therapy Review (DTR) Executive Market Summaries Disease & Therapy Review (DTR) Executive Market Summaries - Product Thumbnail Image

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

March 2015
Analysis of Barclays plc Analysis of Barclays plc - Product Thumbnail Image

Analysis of Barclays plc

Barclays Plc is a major global financial services company based in London. In 2010, the company was measured as being the tenth largest banking and financials services company in the world by Forbes....

February 2015
FROM

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 Summary This, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

January 2015
FROM

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

January 2015
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

January 2015
FROM

Birch Pollen Allergy - Pipeline Review, H1 2015

Birch Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Birch Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Birch Pollen Allergy’s therapeutic pipeline. This report...

January 2015
FROM

Sjogren's Syndrome Global Clinical Trials Review, H2, 2014

Sjogren's Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Sjogren's Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Sjogren’s Syndrome clinical...

December 2014
FROM

Sarcoidosis - Pipeline Review, H2 2014

Sarcoidosis - Pipeline Review, H2 2014 Summary This, ‘Sarcoidosis - Pipeline Review, H2 2014’, provides an overview of the Sarcoidosis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Cedar Pollen Allergy - Pipeline Review, H2 2014

Cedar Pollen Allergy - Pipeline Review, H2 2014 Summary This, ‘Cedar Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Cedar Pollen Allergy’s therapeutic pipeline. This report...

December 2014
FROM

Myasthenia Gravis - Pipeline Review, H2 2014

Myasthenia Gravis - Pipeline Review, H2 2014 Summary This, ‘Myasthenia Gravis - Pipeline Review, H2 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

December 2014
FROM
Immunology Bundle 2014 Immunology Bundle 2014 - Product Thumbnail Image

Immunology Bundle 2014

Available until the 31st of December only, we bring you the most popular seven publications from the immunology sector. Carefully hand-picked by the publisher, we are offering over 4000+ pages of information...

December 2014

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body’s immune system...

December 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Hereditary Angioedema (HAE) - Pipeline Review, H2 2014

Hereditary Angioedema (HAE) - Pipeline Review, H2 2014 Summary This, ‘Hereditary Angioedema (HAE) - Pipeline Review, H2 2014’, provides an overview of the Hereditary Angioedema (HAE)’s therapeutic...

November 2014
FROM

Grass Pollen Allergy - Pipeline Review, H2 2014

Grass Pollen Allergy - Pipeline Review, H2 2014 Summary This, ‘Grass Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Grass Pollen Allergy’s therapeutic pipeline. This report...

November 2014
FROM
Wegener's Granulomatosis - Pipeline Review, H2 2014 Wegener's Granulomatosis - Pipeline Review, H2 2014 - Product Thumbnail Image

Wegener's Granulomatosis - Pipeline Review, H2 2014

Wegener's Granulomatosis - Pipeline Review, H2 2014 Summary This, ‘Wegener's Granulomatosis - Pipeline Review, H2 2014’, provides an overview of the Wegener's Granulomatosis’s therapeutic pipeline. This...

November 2014
FROM

Hypersensitivity - Pipeline Review, H2 2014

Hypersensitivity - Pipeline Review, H2 2014 Summary This, ‘Hypersensitivity - Pipeline Review, H2 2014’, provides an overview of the Hypersensitivity’s therapeutic pipeline. This report provides...

November 2014
FROM

Ragweed Allergy - Pipeline Review, H2 2014

Ragweed Allergy - Pipeline Review, H2 2014 Summary This, ‘Ragweed Allergy - Pipeline Review, H2 2014’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM
Rheumatoid Arthritis - Pipeline Review, H2 2014 Rheumatoid Arthritis - Pipeline Review, H2 2014 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2014

Rheumatoid Arthritis - Pipeline Review, H2 2014 Summary This, ‘Rheumatoid Arthritis - Pipeline Review, H2 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This report...

November 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare